Universitat de ValènciaDepartamento de Farmacología Logo del portal

Principales publicaciones (últimos 10 años)

  1. Marques P, Domingo E, Rubio A, Martinez-Hervás S, Ascaso JF, Piqueras L, Real JT, Sanz MJ. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players. Biomed. Pharmacother. 145:112460 (2022). Impact Factor (JCR 2021): 7.419. Category: PHARMACOLOGY & PHARMACY. Position: 26/279.
  2. Marques P, Fernández-Presa L, Carretero A, Gómez-Cabrera MC, Viña J, Signes-Costa J, Sanz MJ. The radiographic assessment of lung edema score of lung edema severity correlates with inflammatory parameters in patients with coronavirus disease 2019-Potential new admission biomarkers to predict coronavirus disease 2019 worsening. Front. Med. 9: 871714 (2022). Impact Factor (JCR 2021): 5.058. Category: MEDICINE GENERAL AND INTERNAL. Position: 52/172.
  3. Francisco V*, Sanz MJ*,Real JT, Marques P, Capuozzo M, Djedjiga Ait Eldjoudi DA, Gualillo O. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets? Biology (Basel). 11: 1237 (2022). Impact Factor (JCR 2021): 5.168. Category: BIOLOGY. Position: 21/94.
  4. Moreno B, Hueso L, Ortega R, Benito E, Martinez-Hervás S, Peiró M, Civera M, Sanz MJ, Piqueras L, Real JT Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity. Microvasc Res 139:104254 (2022). Impact Factor (JCR 2021): 3.750. Category: PERIPHERAL VASCULAR DISEASE. Position: 30/67.
  5. Vila L, Cabedo N, Villarroel-Vicente C, García A, Bernabeu Á, Hennuyer N, Staels B, Franck X, Figadère B, Sanz MJ, Cortes D. Synthesis and biological studies of "Polycerasoidol" and "trans-δ-Tocotrienolic acid" derivatives as PPARα and/or PPARγ agonists. Bioorg Med Chem. 53: 116532 (2022). Impact Factor (JCR 2021): 3.461. Category: CHEMISTRY, MEDICINAL. Position: 36/63.
  6. Corro-Morón M, Granell A, Ivanova V, Domingo E, Beltrán-Debón R, Barril X, Sanz MJ, Matheu MI, Castillón S, Díaz Y. Revealing 2-Dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as Sphingosine Kinase 2 inhibitors: some hints on the structural basis for selective inhibition. Bioorg Chem. 121:105668 (2022). Impact Factor (JCR 2021): 5.307. Category: CHEMISTRY, ORGANIC. Position: 8/57.
  7. Collado A, Domingo E, Marques P, Perello E, Martinez-Hervás S, Piqueras L, Ascaso JF, Real JT, Sanz MJ. Oral unsaturated fat load impairs postprandial systemic inflammation in primary hypercholesterolemia patients. Front. Pharmacol. 12:656244 (2021). Impact Factor (JCR 2021): 5.988. Category: PHARMACOLOGY & PHARMACY. Position: 40/279.
  8. Ortega R, Hueso L, Benito E, Ortega J, Civera M, *Sanz MJ, *Real JT, *Piqueras L. The nuclear retinoid-related orphan receptor RORα controls adipose tissue inflammation in patients with morbid obesity and diabetes. Int J Obes (Lond). 45:1369-1381 (2021). *Co-last authors. Impact Factor (JCR 2021): 5.551. Category: ENDOCRINOLOGY & METABOLISM. Position: 39/148.
  9. Marques P, Piqueras L, Sanz MJ. An updated overview of e-cigarette impact on human health. Respir Res. 22(1):151 (2021). Impact Factor (JCR 2021): 7.162. Category: RESPIRATORY SYSTEM. Position: 12/65.
  10. Collado A, Domingo E, Piqueras L, Sanz MJ. Primary hypercholesterolemia and development of cardiovascular disorders: cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction. Int J Biochem Cell Biol. 139:106066 (2021). Impact Factor (JCR 2021): 5.652. Category: CELL BIOLOGY. Position: 80/194.
  11. Ríos-Navarro C, Hueso L, Díaz A, Marcos-Garcés V, Bonanad C, Ruiz-Sauri A, Vila JM, Sanz MJ, Chorro FJ, Piqueras L, Bodi V. Role of Antiangiogenic VEGF-A 165 B in Angiogenesis and Systolic Function After Reperfused Myocardial Infarction. Rev Esp Cardiol (Engl Ed) 74:131-139 (2021). Impact Factor (JCR 2021): 5.123. Category: CARDIAC & CARDIOVASCULAR SYSTEMS. Position: 32/143.
  12. Moreno-Pérez B, Benito E, Civera M, Alabadi B, Martinez-Hervas S, Peiro M, González-Navarro H, Piqueras L, Sanz MJ, Ascaso JF, Real JT. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects. Int J Clin Pract. 75 (4):e13776. (2021). Impact Factor (JCR 2021): 3.149. Category: MEDICINE GENERAL AND INTERNAL. Position: 77/172.
  13. Rahman I, Collado Sánchez A, Davies J, Rzeniewicz K, Abukscem S, Joachim J, Hoskins Green HL, Killock D, Sanz MJ, Charras G, Parsons M, Ivetic A. L-selectin regulates human neutrophil transendothelial migration. J Cell Sci. 134(3):jcs250340. (2021). Impact Factor (JCR 2021): 5.235. Category: CELL BIOLOGY. Position: 87/194.
  14. Ascaso P, Palanca A, Martinez-Hervás S, Sanz MJ, Ascaso JF, Piqueras L, Real JT. Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes. Int J Clin Pract. 75 (8):e14302. (2021). Impact Factor (JCR 2021): 3.149. Category: MEDICINE GENERAL AND INTERNAL. Position: 77/172.
  15. Lopez-Riera M, Ortega R, Hueso L, Montesinos MC, Gomez-Cabrera MC, Sanz MJ, Real JT, Piqueras L. Activation of the Constitutive Androstane Receptor Inhibits Leukocyte Adhesiveness to Dysfunctional Endothelium. Int J Mol Sci. 22(17):9267 (2021). Impact Factor (JCR 2021): 6.208. Category: BIOCHEMISTRY & MOLECULAR BIOLOGY. Position: 69/296.
  16. Piqueras L, Sanz MJ. Angiotensin II and Leukocyte Trafficking: New Insights for an Old Vascular Mediator. Role of Redox-Signaling Pathways. Free Radic Biol Med ; 157:38-54. (2020). Impact Factor (JCR 2020): 7.376. Category: ENDOCRINOLOGY & METABOLISM. Position: 17/146.
  17. Sanz MJ, Alcaraz MJ. Pharmacological modulation of redox signaling pathways in disease. Free Radic Biol Med.; 157:1-2. (2020). Impact Factor (JCR 2020): 7.376. Category: ENDOCRINOLOGY & METABOLISM. Position: 17/146.
  18. Silva AG, Vila L, Marques P, Moreno L, Loza M, Sanz MJ, Cortes D, Castro M, Cabedo N. 1-(2'-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors. J Nat Prod. 83 (1):127-133 (2020). Impact Factor (JCR 2020): 4.050. Category: PLANT SCIENCE. Position: 45/235.
  19. Marques P, Collado A, Martinez-Hervás S, Domingo E, Benito E, Piqueras L, Real JT, Ascaso JF, Sanz MJ. Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion. J Clin Med. 8 (5), 708; (2019). Impact Factor (JCR 2019): 3.303. Category: MEDICINE, GENERAL & INTERNAL. Position: 36/165.
  20. Ortega R, Collado A, Selles F, Gonzalez-Navarro H, *Sanz MJ, *Real JT, *Piqueras L. SGLT-2 (Sodium-Glucose Cotransporter 2) Inhibition Reduces Ang II (Angiotensin II)-Induced Dissecting Abdominal Aortic Aneurysm in ApoE (Apolipoprotein E) Knockout Mice. Arterioscler Thromb Vasc Biol. 39:1614-1628 (2019). *Co-last authors. Impact Factor (JCR 2019): 6.604. Category: PERIPHERAL VASCULAR DISEASE. Position: 7/65.
  21. Bermejo A, Collado A, Barrachina I, Marqués P, El Aouad N, Franck X, Garibotto F, Dacquet C, Caignard DH, Suvire FD, Enriz RD, Piqueras L, Figadère B, *Sanz MJ, *Cabedo N, Cortes D. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARg Agonist Activity and Anti-inflammatory Effect. J Nat Prod. 82:1802-1812 (2019). *Co-last authors. Impact Factor (JCR 2019): 3.779. Category: PHARMACOLOGY & PHARMACY. Position: 68/270.
  22. Vinué Á, MartÍnez-Hervás S, Herrero-Cervera A, Sánchez-García V, Andrés-Blasco I, Piqueras L, Sanz MJ, Real JT, Ascaso JF, Burks DJ, González-Navarro H. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus. Transl Res. 203:31-48 (2019). Impact Factor (JCR 2019): 5.411. Category: MEDICINE, RESEARCH & EXPERIMENTAL. Position: 22/138.
  23. Vettorazzi M, Vila L, Lima S, Acosta L, Yépes F, Palma A, Cobo J, Tengler J, Malik I, Alvarez S, Marqués P, Cabedo N, Sanz MJ, Jampilek J, Spiegel S, Enriz RD. Synthesis and biological evaluation of sphingosine kinase 2 inhibitors with anti-inflammatory activity. Arch Pharm (Weinheim). 16:e1800298. (2019). Impact Factor (JCR 2019): 2.590. Category: CHEMISTRY, MULTIDISCIPLINARY. Position: 86/177.
  24. Romero A, San Hipólito-Luengo Á, Villalobos LA, Vallejo S, Valencia I, Michalska P, Pajuelo-Lozano N, Sánchez-Pérez I, León R, Bartha JL, Sanz MJ, Erusalimsky JD, Sánchez-Ferrer CF, Romacho T, Peiró C. The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation. Aging Cell. 17:e12913. (2019). Impact Factor (JCR 2019): 7.238. Category: GERIATRICS & GERONTOLOGY. Position: 3/51.
  25. Vila-Caballer M, González-Granado JM, Zorita V, N Abu Nabah Y, Silvestre-Roig C, Del Monte A, Molina-Sánchez P, Ait-Oufella H, Andrés-Manzano MJ; Sanz MJ, Weber C, Kremer L, Gutiérrez J, Mallat Z, Andrés V. Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice. J Mol Cell Cardiol. 132:154-163. (2019). Impact Factor (JCR 2019): 4.133. Category: CARDIAC & CARDIOVASCULAR SYSTEMS. Position: 36/138.
  26. Bermejo A, Barrachina I, El Aouad N, Franck X, Chahboune N, Andreu I, Figadère B, Vila L, Hennuyer N, Staels B, Dacquet C, Caignard DH, Sanz MJ, Cortes D, Cabedo N. Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators. Bioorg Med Chem. 27(24):115162. (2019). Impact Factor (JCR 2019): 3.073. Category: CHEMISTRY, MEDICINAL. Position: 26/61.
  27. Collado A, Marques P, Escudero P, Rius C, Domingo E, Martinez-Hervás S, Real JT, Ascaso JF, Piqueras L, Sanz MJ. Functional role of endothelial CXCL16/CXCR6-platelet-leukocyte axis in Angiotensin II-associated metabolic disorders. Cardiovascular Res. 114:1764-1775 (2018). Impact Factor (JCR 2018): 
  28. Petri B, Sanz MJ. Neutrophil Chemotaxis. Cell Tissue Res 371:425-436 (2018). Impact Factor (JCR 2018): 3.360. Category: CELL BIOLOGY. Position: 104/193.
  29. Furio E, García-Fuster MJ, Redon J, Marques P, Ortega R, Sanz MJ, Piqueras L. CX3CR1/CX3CL1 AXIS mediates platelet-leukocyte adhesion to arterial endothelium in younger patients with a history of idiopathic deep vein thrombosis. Thrombosis and Haemostasis 118:562-571 (2018). *Co-last authors. Impact Factor (JCR 2018): 4.733. Category: PERIPHERAL VASCULAR DISEASE. Position: 9/65.

  30. Hueso L, Ortega R, Selles F, Wu-Xiong NY, Ortega J, Civera M, Ascaso JF, Sanz MJ Real JT, Piqueras L. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis. Int. J. Obesity. 42:1406-1417 (2018). Impact Factor (JCR 2018): 4.514. Category: ENDOCRINOLOGY & METABOLISM. Position: 29/145.

  31. Plens-Galaska M,  Szelag M, Collado A, Marques P, Vallejo S, Ramos-González M, Wesoly J, Sanz MJ, Peiró C, Bluyssen HAR. Genome-wide inhibition of pro-atherogenic gene expression by multi-STAT targeting compounds as a novel treatment strategy of CVDs. Front. Immunol. 9:2141 (2018). Impact Factor (JCR 2018): 4.716. Category: IMMUNOLOGY. Position: 43/158.
  32. Collado A, Marques P, Domingo E, Perello E, González-Navarro H, Martinez-Hervás S, Real JT, Piqueras L, Ascaso JF, Sanz MJ. Novel Immune Features of the Systemic Inflammation Associated with Primary Hypercholesterolemia: Changes in Cytokine/Chemokine Profile, Increased Platelet and Leukocyte Activation. J Clin Med. 8 (1), 18 (2018). Impact Factor (JCR 2018): 5.688. Category: MEDICINE, GENERAL & INTERNAL. Position: 15/160.
  33. Marques P, Collado A,  Escudero P, Rius C, González C, Servera E, Piqueras L, Sanz MJ. Cigarette smoke increases endotelial CXCL16-leukocyte CXCR6 adhesion in vitro and in vivo. Potential consequences in COPD. Front. Immunol. 8:1766 (2017). Impact Factor (JCR 2017): 5.511. Category: IMMUNOLOGY. Position: 30/155.
  34. Sanz-Garcia C, Sánchez Á, Contreras-Jurado C, Cales C, Barranquero C, Muñóz M, Merino R, Escudero P, Sanz MJ, Osada J, Aranda A, Alemany S. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice. Arterioscler Thromb Vasc Biol. 37:237-246 (2017). Impact Factor (JCR 2017): 6.086. Category: PERIPHERAL VASCULAR DISEASE. Position: 5/ 65.
  35. Tío L, Orellana C, Pérez-García S, Piqueras L, Escudero P, Juarranz Y, Garcia-Giralt N, Montañés F, Farran A, Benito P, Gomariz RP, Sanz MJ, Monfort J. Effect of chondroitin sulphate on synovitis of knee osteoarthritic patients. Med Clin (Barc).149: 9-16 (2017). Impact Factor (JCR 2017): 1.168. Category: MEDICINE, GENERAL & INTERNAL. Position: 94/154.
  36. Hueso L, Ríos-Navarro C, Ruiz-Saurí A, Chorro FJ, Núñez J, Sanz MJ, Bodí V, Piqueras L. Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction. Scientific Reports 7:9962 (2017). Impact Factor (JCR 2017): 4.122. Category: MULTIDISCIPLINARY SCIENCES. Position: 12/64.
  37. Abajo FJ, Albanell F, Delgado-Sánchez O, Klein K, Moreno-Muelas JV, Ruiz S, Sanz MJ, Thorpe R, Zaragoza F. Roundatable on biosimilars: Pharmacovigilance, traceability, immunogenicity, 15 November 2016, SpainGaBi Journal .6: 31-37 (2017).
  38. Parravicini O, Bogado ML, Rojas S, Angelina EL, Andujar SA, Gutierreza,LJ, Cabedo N,  Sanz MJ, M. López-Gresa MP, Cortes D, Enriz RD. Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 Dopamine Receptor. J. Mol. Model. 23:273 (2017). Impact Factor (JCR 2017): 1.507. Category: CHEMISTRY, MULTIDISCIPLINARY. Position: 105/170.
  39. Ríos-Navarro C, Hueso L, Miñana G, Núñez J, Ruiz-Saurí A, Sanz MJ, Cànoves J, Chorro FJ, Piqueras L, Bodí V. Coronary Serum Obtained After Myocardial Infarction Induces Angiogenesis and Microvascular Obstruction Repair. Role of Hypoxia-inducible Factor-1α. Rev. Esp. Cardiol. S1885-5857 (17): 30361-30364 (2017). Impact Factor (JCR 2017): 5.166. Category: CARDIAC & CARDIOVASCULAR SYSTEMS. Position: 26/128.
  40. Párraga J, Andujar SA, Rojas S, Gutierrez LJ, El Aouad N, Sanz MJ, Enriz RD, Cabedo N, Cortes D. Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands. Eur. J.Med.Chem. 122:27-42. (2016). Impact Factor (JCR 2016): 4.519. Category: CHEMISTRY, MEDICINAL. Position: 4/60.
  41. Martorell S, Hueso L, Gonzalez-Navarro H, Collado A, *Sanz MJ, *Piqueras L. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice. Arterioscler Thromb Vasc Biol. 36:1587-1597 (2016). *Co-last authors. Impact Factor (JCR 2016): 6,607. Category: PERIPHERAL VASCULAR DISEASE. Position: 4/63.
  42. Andrés-Blasco I, Vinué Á, Herrero-Cervera A, Martínez-Hervás S, Nuñez L, Piqueras L, Ascaso JF, Sanz MJ, Burks DJ, González-Navarro H. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/Lymphotoxinβ-Receptor pathway. Thromb. Haemost. 116:379-393 (2016). Impact Factor (JCR 2016): 5.627. Category: PERIPHERAL VASCULAR DISEASE. Position: 6/63.
  43. Andrés-Blasco I, Herrero-Cervera A, Vinué A, Martínez-Hervás S, Piqueras L, Sanz MJ, Burks DJ, González-Navarro H. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J. Endocrinol. 227:179-191(2015). Impact Factor (JCR 2015):4,498. Category: ENDOCRINOLOGY & METABOLISM. Position: 27/131.
  44. Párraga J, Galán A, Sanz MJ, Cabedo N, Cortes D. Synthesis of hexahydrocyclopenta [ij] isoquinolines as a new class of dopaminergic agents. Eur. J. Med. Chem. 90: 101-106 (2015). Impact factor (JCR 2015): 3,902. Category: CHEMISTRY, MEDICINAL. Position: 6 de 59.
  45. Vinué Á, Andrés-Blasco I, Herrero-Cervera A, Piqueras L, Andrés V, Burks DJ, Sanz MJ, González-Navarro H. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling. Biochim Biophys Acta. Molecular Basis of Disease 1852:1729-1742 (2015). Impact Factor (JCR 2015): 5,158. Category: BIOCHEMISTRY & MOLECULAR BIOLOGY. Position: 49/289.
  46. Kolaczkowska E, Jenne CN, Surewaard BG, Thanabalasuriar A, Lee WY, Sanz MJ, Mowen K, Opdenakke G, Kubes P. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat. Commun. 6:6673. doi: 10.1038/ncomms7673 (2015). Impact Factor (JCR 2015): 11,329. Category: MULTIDISCIPLINARY SCIENCES. Position: 3/63
  47. Escudero P, Martinez de Marañón A, Collado A, Gonzalez-Navarro H, Hermenegildo C, Peiró C, Piqueras L, Sanz MJ. Combined sub-optimal doses of Rosuvastatin and Bexarotene impairs angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions”. Antioxid Redox Signal., 22:901-920 (2015). Impact Factor (JCR 2015): 7.093. Category: ENDOCRINOLOGY & METABOLISM. Position: 11/131.
  48. Escudero P, Navarro A, Ferrando C, Furió E, Gonzalez-Navarro H, Juez M, *Sanz MJ, *Piqueras L.Combined treatment with Bexarotene and Rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE-/- mice and angiogenesis. Br. J. Pharmacol. 172: 2946-2960 (2015).* Co-last authors. Impact Factor (JCR 2015): 5.259. Category: PHARMACOLOGY & PHARMACY. Position: 17/253

  49. Boulangé A, Parraga J, Cabedo N, Galán A, Leleu S; Cortes D, Sanz MJ, Franck X. "Synthesis and antibacterial activities of cadiolides A, B and C and analogues”. Bioorgan. Med. Chem. 23:3618-3628 (2015. Impact factor: (JCR 2015): 2,923. Categoría: CHEMISTRY, MEDICINAL. Posición dentro de la categoría: 20/59.

  50. Lee WY*, Sanz MJ*, Wong CH, Hardy PO, Salman-Dilgimen A, Moriarty TJ, Chaconas G, Marques A, Krawetz R, Mody CH, Kubes P. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia. Proc Natl Acad Sci U S A. 111:13936-13941. (2014). * Co-first author. Impact Factor (JCR 2014): 9.674. MULTIDISCIPLINARY SCIENCES. Position: 4/56.
  51. Martínez-Hervás S, Vinué A, Núñez L, Andrés-Blasco I, Piqueras L, Real JT, Ascaso JF, Burks DJ, Sanz MJ, González-Navarro H. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis. Cardiovasc. Res. 103:324-336 (2014). Impact Factor (JCR 2014): 5.940. Category: CARDIAC & CARDIOVASCULAR SYSTEM. Position:12/123
  52. González-Navarro H, Vinué A, Sanz MJ, Delgado M, Pozo MA, Serrano M, Burks DJ, Andrés V. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging. Aging Cell 12: 102-111 (2013). Impact Factor (JCR 2013): 5.939. Category: GERIATRICS & GERONTOLOGY. Position:2/49
  53. Rius C, Company C, Piqueras L, Cerdá-Nicolás M, González C, Servera E, Ludwig A, Morcillo EJ, Sanz MJ. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium. Thorax. 68: 177-186 (2013). Impact Factor (JCR 2013): 8.562. Category: RESPIRATORY SYSTEM. Position:2/53
  54. Rius C, Piqueras L, González-Navarro H, Albertos F, Company C, López-Ginés C, Ludwig A, Blanes JI, Morcillo EJ, Sanz MJ. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. .Arterioscler Thromb Vasc Biol. 33: 96-104 (2013). Impact Factor (JCR 2013): 5.533. Category: HEMATOLOGY. Position:8/68
  55. Sanz MJ,  Albertos F, Otero E, Juez M, Morcillo EJ, Piqueras L. Retinoid X Receptor (RXR) agonists impair arterial mononuclear cell recruitment through peroxisome proliferator–activated receptor gamma activation. J. Immunol. 189: 411-424 (2012). Impact Factor (JCR 2012): 5.520. Category: IMMUNOLOGY. Position:24/135
  56. Sanz MJ, Kubes-P. Neutrophil-active chemokines in in vivo imaging neutrophil trafficking. Eur. J. Immunol. 42: 278–283 (2012). Impact Factor (JCR 2012): 4.970. Category: IMMUNOLOGY. Position:26/135